Nursing Care and Education in Viral Hepatitis

Berkay ALİKANa,b, Kimya KILIÇASLANa,b, Gülbeyaz CANb
aİstanbul University-Cerrahpaşa Institute of Graduate Studies, İstanbul, Türkiye
bİstanbul University-Cerrahpaşa Florence Nightingale Faculty of Nursing, İstanbul, Türkiye

Alikan B, Kılıçaslan K, Can G. Nursing care and education in viral hepatitis. In: Oğuz S, ed. Nursing Care and Education in Gastrointestinal System Diseases. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.32-40.

ABSTRACT
Viral hepatitis is a disease that, causes inflammation of the liver and irreversible damage to liver cells. Which can cause various complications, such as cirrhosis and liver cancer. Viral Hepatitis is an important problem seen all over the world, which adversely affects the country’s economy and increases the health burden of the countries. The diagnosis, treatment and prevention should be chosen according to the type of viral hepatitis. Nursing care of the viral hepatitis is another important aspect of the treatment process. The main goal of nursing care is the prevention and prevention of viral hepatitis. To achieve this goal nurses must raise awareness by providing education about prevention methods, prevent mother-to-baby transmission, increase immunization among their community, monitor viral hepatitis patients, increase access to treatment, provide safe blood products and prevent healthcare-related hepatitis.

Keywords: Hepatitis; viral hepatitis; hepatitis A; hepatitis B; hepatitis C; nursing care

Referanslar

  1. WHO. Global Hepatitis Report 2017 [Internet]. Geneva; 2017 [cited 2023 Oct 6]. Available from: [Link]
  2. WHO. Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. [Internet]. Geneva; 2022 [cited 2023 Oct 6]. Available from: [Link]
  3. Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736-88. [Crossref]  [PubMed]
  4. Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. [Crossref]  [PubMed]
  5. Zeng DY, Li JM, Lin S, Dong X, You J, Xing QQ, et al. Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990-2019. J Hepatol. 2021;75(3):547-56. [Crossref]  [PubMed]
  6. Wiktor SZ. Viral Hepatitis. In: Holmes KK, Bertozzi S, Bloom BR, et al., editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 16. Available from: https://www.ncbi.nlm.nih.gov/books/NBK525186/ doi: 10.1596/978-1-4648-0524-0_ch16 [Crossref]  [PubMed]
  7. Zarrin A, Akhondi H. Viral Hepatitis. [Updated 2023 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: [Link]
  8. Irmak H, Yardım N, Keklik K, Temel F. Türkiye Viral Hepatit Önleme ve Kontrol Programı 2018-2023. Ankara; 2019.
  9. Odenwald MA, Paul S. Viral hepatitis: Past, present, and future. World J Gastroenterol. 2022;28(14):1405-29. [Crossref]  [PubMed]  [PMC]
  10. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-99. [Crossref]  [PubMed]  [PMC]
  11. MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med. 2015;5(5):a021410. [Crossref]  [PubMed]  [PMC]
  12. Croagh CM, Desmond PV, Bell SJ. Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance. World J Hepatol. 2015;7(3):289-303. [Crossref]  [PubMed]  [PMC]
  13. Pardee M. Diagnosis and Management of Hepatitis B and C. Nurs Clin North Am. 2019;54(2):277-84. [Crossref]  [PubMed]
  14. Dubuisson J, Cosset FL. Virology and cell biology of the hepatitis C virus life cycle: an update. J Hepatol. 2014;61(1 Suppl):S3-S13. [Crossref]  [PubMed]
  15. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22(34):7824-40. [Crossref]  [PubMed]  [PMC]
  16. Rizzetto M. Hepatitis D Virus: Introduction and Epidemiology. Cold Spring Harb Perspect Med. 2015;5(7):a021576. [Crossref]  [PubMed]  [PMC]
  17. Khuroo MS, Khuroo MS, Khuroo NS. Hepatitis E: Discovery, global impact, control and cure. World J Gastroenterol. 2016;22(31):7030-45. [Crossref]  [PubMed]  [PMC]
  18. Can G, Akyuz F. İç Hastalıkları Hemşireliği. 3. Baskı. In: Enç N, editör. İstanbul: Nobel Tıp Kitabevi; 2020.
  19. Sinn DH, Cho EJ, Kim JH, Kim DY, Kim YJ, Choi MS. Current status and strategies for viral hepatitis control in Korea. Clin Mol Hepatol. 2017;23(3):189-95. [Crossref]  [PubMed]  [PMC]